Patents Examined by S. L.
-
Patent number: 11970226Abstract: An elastic crawler capable of effectively preventing an occurrence of vibration, noise and cracks during driving while improving durability is provided. The elastic crawler includes a coupling portion arranged at equal intervals in a circumferential direction at a center in a left and right direction of a crawler body, a steel core arranged in the left and right direction between adjacent coupling portions in the circumferential direction of the crawler body, and two rows of left and right lugs installed on an outer periphery of the crawler body, wherein each of the rows of the lugs includes driving lugs arranged in an oblique direction with respect to the steel core, and each of the driving lugs overlaps with two adjacent steel cores in the circumferential direction.Type: GrantFiled: November 9, 2020Date of Patent: April 30, 2024Inventor: Yong Jae Choi
-
Patent number: 11932049Abstract: Assembly of a rim and of a flexible adapter, intended to make up, with a tyre, a rolling assembly. The rim having a mounting well that is extended axially by a boss, a rim seat and a rim flange that extends the rim seat axially on the outside, with a bearing face of substantially radial orientation. The adapter having an axially inner end intended to rest on the rim seat, an axially outer end and a substantially cylindrical body that connects the axially inner end and the axially outer end and is intended to receive, in cooperation with the axially outer end, a tyre bead. The rim seat of the rim has an inclination relative to the axis of rotation of between ?2 and +6 degrees, the angle being counted as positive when the virtual vertex of the substantially frustoconical seat is situated axially on the outside.Type: GrantFiled: June 7, 2019Date of Patent: March 19, 2024Assignee: MAXION WHEELS HOLDING GMBHInventors: Daniel Walser, Johan Vits, Bertrand Vedy
-
Patent number: 11919585Abstract: A track tension system including a hydraulic cylinder coupled between a drive frame and idler of a track system, an accumulator and a hydraulic valve that controls flow between the cylinder and accumulator. The cylinder extends and retracts to change the distance between the drive frame and idler which increases and decreases, respectively, tension on the track system. The hydraulic valve can be opened to allow flow between the cylinder and accumulator, and closed to block flow between the cylinder and accumulator. Control factors can be monitored to control valve position. An overload pressure relief can allow flow between the cylinder and accumulator when the hydraulic valve is closed and pressure in the cylinder reaches overload pressure. An orifice can allow constricted flow between the cylinder and accumulator when the hydraulic valve is closed. A check valve can connect the track tension system to a vehicle hydraulic system.Type: GrantFiled: July 15, 2019Date of Patent: March 5, 2024Assignee: DEERE & COMPANYInventors: Bruce S. Johnson, Dennis A. Bowman, Benjamin J. Heimbuch, Daniel J. Garvin, Randall K. Bill, Jeremy P. L'Heureux
-
Patent number: 11912355Abstract: An endless track vehicle with increased traction and/or installation, modification, and/or use of track cleats for traction for the endless track of the endless track vehicle. A body is mountable to the endless track exterior. The body defines bores extending from a first end of the body to a second end of the body, wherein the bores have counterbores. First and second cleats/bolts respectively having a cleat/bolt heads, the cleats/bolts mounted in respective bores and optional extending out a distance out of the second end of the body, wherein the cleat/bolt heads seat in the respective counterbores. Nuts may be used in the counterbores to optionally extend the cleats/bolts, and/or to secure and fasten the cleats/bolts.Type: GrantFiled: December 14, 2020Date of Patent: February 27, 2024Assignee: Quanta Associates, L.P.Inventor: Daniel Robert Berube
-
Patent number: 9237107Abstract: Technologies are generally described for an enhanced Quantized Congestion Notification (QCN) congestion control approach, referred to as Fair QCN (FQCN) for enhancing fairness of multiple flows sharing link capacity in a high bandwidth, low latency data center network. QCN messages may be fed back to flow sources (e.g., servers) which send packets with a sending rate over their share of the bottleneck link capacity. By enabling the flow sources to regulate their data traffic based on the QCN messages from a congestion control component, the queue length at the bottleneck link may converge to an equilibrium queue length rapidly and TCP throughput performance may be enhanced substantially in a TCP incast circumstance.Type: GrantFiled: November 15, 2011Date of Patent: January 12, 2016Assignee: NEW JERSEY INSTITUTE OF TECHNOLOGYInventors: Nirwan Ansari, Yan Zhang
-
Patent number: 6698626Abstract: A lint remover and spray dispenser apparatus rotatably supports a tubular adhesive lint remover tape roll or fixedly supports a single strip or multiple strips of a directional lint remover fabric. The apparatus includes an elongated handle section and a cylindrical or oblong support section. The elongated handle has an open end having external threads adjacent to the open end. A spray top having a hand pump and a threaded cap is mounted on the elongated handle. The liquid container-handle combination may be a molded polymer container having a trigger activated spray pump attached thereto. Alternately, the handle is configured to receive a separate liquid spray dispenser container.Type: GrantFiled: May 10, 2002Date of Patent: March 2, 2004Inventor: William D. McKay
-
Patent number: 6659310Abstract: A product dispensing and drainback fitting, for directing the flow of a liquid product from a container and minimizing the occurrence of double pour, having an outer wall for engagement with the neck of said container; an inner spout centrically positioned within said outer wall, a base extending between said wall and said spout and creating a circumscribing well, a longitudinal slot formed in said inner spout, said longitudinal slot beginning at a point about 30 mm to about 48 mm above said base and extending the remainder of the length of said spout; and drainback hole formed in said base and aligned with said longitudinal slot, said drainback hole having an area of about 10 mm2 to about 20 mm2.Type: GrantFiled: March 14, 2000Date of Patent: December 9, 2003Assignee: The Dial CorporationInventor: Christopher J. Wolpert
-
Patent number: 6207648Abstract: Methods of killing neoplastic cells are provided. The invention relates to the use of NADPH-cytochrome P450 reductase (RED) gene transfer in combination with cytochrome P450 gene transfer to enhance the sensitivity of tumor cells to anti-cancer drugs that are activated by P450 enzymes. The use of bioreductive drugs that are activated by RED and/or cytochrome P450, in this paradigm, is also provided.Type: GrantFiled: July 17, 1998Date of Patent: March 27, 2001Assignee: Trustees of Boston UniversityInventors: David J. Waxman, Ling Chen
-
Patent number: 6177540Abstract: This invention relates to pressure sensitive adhesives, and processes of preparing such adhesives, comprising random star polymers which are crosslinked by reaction with multifunctional crosslinking agent. These adhesives can be used in coated articles.Type: GrantFiled: November 12, 1998Date of Patent: January 23, 2001Assignee: National Starch and Chemical Investment Holding CorporationInventors: Robert D. Harlan, Jules E. Schoenberg, Christopher G. Gore, Deepak Hariharan, Smita M. Shah
-
Patent number: 5256643Abstract: A new human gene designated as "CRIPTO" gene has been identified and cloned. CRIPTO gene products and derivatives thereof have been obtained and various utilities of the same have been described. Association of CRIPTO gene with cancers, such as colorectal cancer and breast carcinoma, has been indicated.Type: GrantFiled: May 29, 1990Date of Patent: October 26, 1993Assignee: The Government of the United StatesInventors: Maria G. Persico, David S. Salomon
-
Patent number: 5238916Abstract: This invention provides a purified polypeptide having growth factor activity and a defined amino acid sequence. The invention also provides a purified nucleic acid molecule encoding the polypeptide. This invention further provides methods for producing the polypeptide as well as uses thereof. Finally, this invention provides methods for detecting the polypeptide.Type: GrantFiled: May 27, 1988Date of Patent: August 24, 1993Assignee: The Trustees of Columbia University in the City of New YorkInventors: Mitchell Goldfarb, Xi Zhan
-
Patent number: 5208631Abstract: A technique to identify colorimetric properties of toner contained within a cartridge in a reproduction machine by embedding in a PROM within the cartridge specific coordinates of a color coordinate system and entering the color coordinate information into the data base of the machine to accurately map color data from one color domain such as a full color domain to another color domain such as a highlight color domain.Type: GrantFiled: December 9, 1991Date of Patent: May 4, 1993Assignee: Xerox CorporationInventors: Timothy W. Jacobs, David M. Korvick
-
Patent number: 5200327Abstract: A gene expression system is used to produce heterologous biologically active proteins, in particular bioactive granulocyte macrophage colony stimulating factor ("GM-CSF"), secreted from a host selected from the Streptomyces genera. The gene expression system includes a regulatory nucleotide sequence linked to a second nucleotide sequence encoding the heterologous protein. The regulatory sequence, encodes a peptide which directs the secretion of the heterologous protein in bioactive form from a host selected from the Streptomyces genera. The regulatory sequence includes a signal sequence and a promoter sequence. The second nucleotide sequence, which encodes GM-CSF or a biologically active derivative of GM-CSF, may be either natural or synthetic. In particular, the invention relates to an expression system for secreting bioactive, non-glycosylated, oxidized, therapeutically useful GM-CSF from a host selected from the Streptomyces genera.Type: GrantFiled: July 26, 1988Date of Patent: April 6, 1993Assignee: Cangene CorporationInventors: Robert T. Garvin, Lawrence T. Malek
-
Patent number: 5196335Abstract: A double-stranded cDNA molecule which includes DNA encoding human cytoplasmic superoxide dismutase has been created. The sequence of one strand of a double-stranded DNA molecule which encodes human cytoplasmic superoxide dismutase has been discovered. Such molecules may be introduced in procaryotic, e.g., bacterial, or eucaryotic, e.g., yeast or mammalian, cells and the resulting cells cultured or grown under suitable conditions so as to produce human cytoplasmic superoxide dismutase which may then be recovered.Type: GrantFiled: July 2, 1990Date of Patent: March 23, 1993Assignee: Yeda Research and Development Co., Ltd.Inventor: Yoram Groner
-
Patent number: 5194376Abstract: A baculovirus expression system capable of producing foreign gene proteins at high levels. The system involves the production of a recombinant baculovirus containing a modified foreign gene between the polyhedrin gene promoter region and the transcription termination signal of the polyhedrin structural gene. The modified foreign gene comprises a putative ribosome binding site immediately upstream of the foreign gene coding sequence, i.e. without any intervening non-coding sequences. The putative ribosome binding site is preferably properly positioned without the intervening sequences by a crossover linker mutagenesis procedure before the modified foreign gene is introduced into the virus. The putative ribosome binding site preferably comprises at least the final four nucleotides of the sequences ACCTATAAAT immediately upstream of the translation inibiation codon (ATG) of the foreign gene.Type: GrantFiled: February 28, 1989Date of Patent: March 16, 1993Assignee: University of OttawaInventor: C. Yong Kang
-
Patent number: 5182196Abstract: Recombinant DNA molecules comprising DNA sequences derived from bacteriophage T4 that are useful in expressing desired polypeptides in unexpectedly high yields, hosts and expression systems comprising such recombinant DNA molecules and methods for expressing desired polypeptides in high yields by the utilization of such hosts and expression systems.Type: GrantFiled: June 27, 1989Date of Patent: January 26, 1993Assignee: Biogen, Inc.Inventors: Bernard Allet, Eric H. Kawashima
-
Patent number: 5171677Abstract: A recombinant Marek's disease virus which comprises a Marek's disease virus genom and a DNA fragment incorporated therein, said DNA fragment being constructed by incorporating a promoter derived from an animal cell or an animal virus and a structural gene coding for an exogenous protein into a gene fragment derived from a Marek's disease virus, a process for preparing the same which comprises preparing a gene fragment wherein a structural gene coding for an exogenous gene is linked to the downstream of a promoter derived from an animal cell or an animal virus, incorporating said gene fragment into a BamHI - H fragment of a gene of a Marek's disease virus type I, and incorporating said fragment into a Marek's disease virus type I genome, and a multivalent live vaccine for birds comprising the same.Type: GrantFiled: September 8, 1989Date of Patent: December 15, 1992Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research InstituteInventors: Masashi Sakaguchi, Hiroaki Maeda, Michitaka Yamamoto, Junichi Miyazaki
-
Patent number: 5169784Abstract: This invention relates to specifically designing and genetically engineering recombinant baculovirus for producing, in a compatible insect system, a desired protein, virus, protein hybrid, or virus hybrid. In particular aspects, this invention relates to the use of different baculovirus promoters for the ultimate purpose of constructing a recombinant baculovirus designed for the investigator's specific need. For example, the recombinant baculovirus of this invention can be designed to produce a viral pesticide.This invention also describes the construction of a genetically engineered virus or virus hybrid (e.g. animal or human pathogen) which is not capable of replicating itself but is essentially identical to the authentic pathogen in terms of structure and antigenicity.Type: GrantFiled: September 17, 1990Date of Patent: December 8, 1992Assignee: The Texas A & M University SystemInventors: Max D. Summers, Christian E. G. Oker-Blom
-
Patent number: 5162217Abstract: An improved plasmid for the production of superoxide dismutase which upon introduction into a host containing the thermolabile repressor C.sub.I renders the host capable of effecting expression of a gene encoding superoxide dismutase. The plasmid which includes in 5' to 3' order the following: the promoter and operator P.sub.L O.sub.L from lambda bacteriophage; the N utilization site; a first restriction enzyme site permitting replacement of the ribosomal binding site which follows thereafter; a ribosomal binding site; an ATG initiation codon; a second restriction enzyme site; a gene encoding superoxide dismutase; an origin of replication and a gene associated with a selectable or identifiable phenotypic trait manifested when the plasmid is present in the host. The distance between the 3' end of P.sub.L O.sub.L and the 5' end of the N utilization site is less than about 80 base pairs.Type: GrantFiled: December 8, 1989Date of Patent: November 10, 1992Assignee: Bio-Technology General Corp.Inventors: Jacob R. Hartman, Amos B. Oppenheim, Marian Gorecki, Haim Aviv, Rachel Oren
-
Patent number: 5159068Abstract: A DNA sequence, characterized by coding the main subunits of the ATP synthase from methanogenic bacteria.Type: GrantFiled: May 24, 1990Date of Patent: October 27, 1992Assignee: Mitsubishi Denki Kabushiki KaishaInventors: Kenichi Inatomi, Masamitsu Futai